...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Message: About that stroke failure

"Thanks.  Is it odd in your mind that it was ineffective for stroke?"

And I forgot to mention that there were no strokes reported in the post-hoc analysis of the Phase 2 ASSURE/SUSTAIN 5-point MACE. Therefore, there is no precedent in the Phase 2s that apabetalone lowered risk of stroke.



New Message
Please login to post a reply